Chris Silvin
Impact in
- Immunology top 10%
- Immune cells in cancer
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Phagocytosis and Immune Regulation
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 3
- Cancer Immunotherapy and Biomarkers 1
- Chemokine receptors and signaling 1
- CAR-T cell therapy research 1
-
- Immune cells in cancer 2
- Immune Cell Function and Interaction 1
- Phagocytosis and Immune Regulation 1
- Co-authors
- Clint Allen (3 shared papers)Paúl E. Clavijo (3 shared papers)Jay Friedman (3 shared papers)Carter Van Waes (2 shared papers)Zhong Chen (1 shared paper)Ruth J. Davis (1 shared paper)Ellen Moore (1 shared paper)Harrison Cash (1 shared paper)
- Journals
- Advances in experimental medicine and biology (1 paper)Journal for ImmunoTherapy of Cancer (1 paper)Cancer Research (1 paper)JCI Insight (1 paper)
- Partner nations
- United StatesGermanyCanada
In The Last Decade
Chris Silvin
4 papers receiving 412 citations
Peers
Comparison fields: 5 of 42
- Immunology 321
- Oncology 265
- Neurology 12
- Genetics 13
- Psychiatry and Mental health 14
Countries citing papers authored by Chris Silvin
This map shows the geographic impact of Chris Silvin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chris Silvin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chris Silvin more than expected).
Fields of papers citing papers by Chris Silvin
This network shows the impact of papers produced by Chris Silvin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chris Silvin. The network helps show where Chris Silvin may publish in the future.
Co-authors
The 25 scholars most cited alongside Chris Silvin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 194 | |
| 2 | 2017 | 183 | |
| 3 | 2021 | 36 | |
| 4 | 2011 | 5 |
About Chris Silvin
Chris Silvin is a scholar working on Oncology, Immunology, Molecular Biology, Ophthalmology and Cell Biology, having authored 4 papers that have together received 418 indexed citations. Recurring topics across this work include Immune cells in cancer (2 papers), Retinal Diseases and Treatments (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), Chemokine receptors and signaling (1 paper), Immune Cell Function and Interaction (1 paper), Phagocytosis and Immune Regulation (1 paper), CAR-T cell therapy research (1 paper) and Retinal Development and Disorders (1 paper). The work is most often cited by research in Immunology (321 citations), Oncology (265 citations), Neurology (12 citations), Genetics (13 citations) and Psychiatry and Mental health (14 citations). Chris Silvin has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include Clint Allen, Paúl E. Clavijo, Jay Friedman, Carter Van Waes, Zhong Chen, Ruth J. Davis, Ellen Moore, Harrison Cash, Jeffrey Schlom and Yvette Robbins. Their work appears in journals such as Advances in experimental medicine and biology, Journal for ImmunoTherapy of Cancer, Cancer Research and JCI Insight.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.